April 5, 11:37 AMVaccines ExaminerNorma Erickson
On March 12, 2010, six very special women from around the world were honored to be able to present their research regarding the two currently licensed HPV vaccines, Gardasil and Cervarix, to several FDA department heads via webinar.
One of these women was Leslie Carol Botha, internationally recognized expert on women’s hormone cycles and the relationship between endocrine balance and healthcare. Her multi-faceted background includes broadcast journalism, health education and public speaking. Leslie is also the author of a multitude articles relating to hormone cycles and healthcare. She was awarded the Edward R. Dewey Award in 2006 for her “pioneering work in female hormones and behaviors,” from the Foundation for the Study of Cycles. Leslie is a longstanding member of the Society for Menstrual Cycle Research.
You can learn more about Leslie’s work by visiting “Holy Hormones Honey, The Greatest Story Never Told.”
In spite of her many current projects, Leslie graciously agreed to take time out of her busy schedule to explain exactly how she became involved in the HPV vaccine controversy and what part she played in the recent presentation to the FDA concerning the risks involved with the currently licensed HPV vaccines, Gardasil and Cervarix.
Leslie, I understand you were concerned about the HPV virus even before the introduction of Gardasil and Cervarix, is that true?
Yes, it is. I host a bi-monthly radio talk show that focuses on anything and everything having to do with hormones and the relationship of endocrine balance and healthcare. I hosted several shows aimed at educating women of all ages regarding the transmission of the HPV virus. I always tried to stress that a strong immune system is the best defense against any viral infection, including the HPV virus. I also made a substantial effort to let people know that HPV generally passes through a woman’s body in two years time with, or without treatment.
Several of your articles express concerns about the timing of medical treatments, can you explain a little about those concerns?
Of course. My research has clearly shown a strong relationship between the effectiveness of medical treatments such as antibiotics, medications and even surgical procedures to the phases of a woman’s menstrual cycle. Medical treatments given during the paramenstrum (premenstrual and menstrual phases) have an increased risk of negative side effects and a decreased chance of success. There is also a significantly longer recovery time for medical procedures performed during the paramenstrum. When these same procedures occur around ovulation, there is a much greater chance of experiencing a successful outcome, and a decreased incidence of negative side effects.